LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 33.32 84.90 1820 2722 0.6685 0.8453
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 33.32 84.90 1859 2722 0.6829 0.8532
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 33.32 84.90 144 2722 0.0529 0.1114
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 33.32 84.90 1777 2722 0.6527 0.8365
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 35.03 84.90 69 2991 0.0231 -0.0395
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 35.03 84.90 1720 2991 0.5750 0.7958
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 35.03 84.90 1957 2991 0.6542 0.8415
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 35.03 84.90 1992 2991 0.6659 0.8479
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 35.03 84.90 161 2991 0.0538 0.1326
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 35.03 84.90 1813 2991 0.6061 0.8143
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 84.90 64 3254 0.0197 -0.0523
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 84.90 1808 3254 0.5556 0.7886
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 84.90 1978 3254 0.6078 0.8194
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 84.90 2001 3254 0.6149 0.8234
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 84.90 188 3254 0.0578 0.1632
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 84.90 1925 3254 0.5915 0.8100
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 38.43 84.90 88 3459 0.0254 0.0067
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 38.43 84.90 1865 3459 0.5391 0.7818
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 38.43 84.90 2113 3459 0.6108 0.8239
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 38.43 84.90 2134 3459 0.6168 0.8273
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 38.43 84.90 244 3459 0.0705 0.2182
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 38.43 84.90 1975 3459 0.5709 0.8010
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 40.14 84.90 110 3682 0.0299 0.0488
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 40.14 84.90 1996 3682 0.5421 0.7870
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 40.14 84.90 2210 3682 0.6002 0.8208
MN20160318_Q02
K07